Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study

A. ILHAME ; C. DONADILLE ; C. PROTOPOPESCU ; D. MICHELS ; J. HERIN ; A. PLADYS ; D. BADER ; P. CARRIERI ; P. ROUX | 2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique

BACKGROUND: Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing i[...]

Plus d'info

Ajouter à la sélection

Lien externe